Rodrigo S. Delfino
Sao Paulo, SP, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Role of concomitant benzodiazepines, lithium, and lamotrigine in modulating the antidepressant effects of subcutaneous esketamine in patients with treatment-resistant depressive episodes: A retrospective naturalistic study.
Journal: Journal of affective disorders
Published: February 12, 2026
Systematic review and meta-analysis of intranasal esketamine for treatment-resistant depression: Evidence from real-world studies.
Journal: Journal of affective disorders
Published: September 26, 2025
Editorial: Perspectives on new fast-acting antidepressants.
Journal: Frontiers in psychiatry
Published: May 10, 2024
Authors' Response to Comment on "Efficacy and Safety of Subcutaneous Esketamine in the Treatment of Suicidality in Major Depressive Disorder and Bipolar Depression".
Journal: Clinical drug investigation
Published: October 27, 2022
Efficacy and Safety of Subcutaneous Esketamine in the Treatment of Suicidality in Major Depressive Disorder and Bipolar Depression.
Journal: Clinical drug investigation
Published: August 11, 2022
Repeated subcutaneous esketamine for treatment-resistant depression: Impact of the degree of treatment resistance and anxiety comorbidity.
Journal: Journal of psychopharmacology (Oxford, England)
Published: January 11, 2021
A Clinical Rationale for Assessing the Impact of Childhood Sexual Abuse on Adjunctive Subcutaneous Esketamine for Treatment-Resistant Depression.
Journal: Frontiers in psychiatry
Published: September 20, 2020
Effects of subcutaneous esketamine on blood pressure and heart rate in treatment-resistant depression.
Journal: Journal of psychopharmacology (Oxford, England)
Published: July 09, 2020
The probability of response after each subcutaneous injection of esketamine in treatment-resistant depression.
Journal: Revista de psiquiatria y salud mental
Published: June 17, 2020
The probability of response after each subcutaneous injection of esketamine in treatment-resistant depression.
Journal: Revista de psiquiatria y salud mental
Published: June 17, 2020
Comparative effectiveness of esketamine in the treatment of anhedonia in bipolar and unipolar depression.
Journal: Journal of affective disorders
Published: June 06, 2020
Repeated subcutaneous esketamine administration for depressive symptoms and pain relief in a terminally ill cancer patient: A case report.
Journal: Palliative medicine
Published: March 19, 2020
Showing 1-12 of 12
Last Updated: 09/26/2026